arrow
N

Nahúm Méndez‐Sánchez

University of Antwerp
H-index:62
Citation Count:2.0万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

THE SIMPLEST HEPATOPROTECTIVE INTERVENTION? COFFEE IN THE ERA OF PRECISION HEPATOLOGY

最简单的保肝干预?精准肝病学时代的咖啡

2026-08-210
PRE
Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review
2026-08-050
PRE
Delphi survey to explore core curriculum for training the next generation of hepatologists

德尔菲调查探索下一代肝病学家培训的核心课程

2026-08-010
OAAI
Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD

幽门螺杆菌感染与NAFLD、MAFLD、MASLD及中国MAFLD的关联

2026-07-310
PRE
From NAFLD to MASLD and MetALD: Conceptual Shifts in Metabolic Liver Disease and Their Implications for Mexico

从NAFLD到MASLD和MetALD:代谢性肝病概念上的转变及其对墨西哥的影响

2026-05-090
PRE
Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence
2026-01-300
PRE
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications

GLP-1受体激动剂与胆囊疾病风险:分子机制与临床意义的洞察

2025-12-230
OA
Identifying Low-Risk Patients with Cirrhosis and Acute Gastrointestinal Bleeding That May Not Require Urgent Endoscopy

识别可能不需要紧急内镜检查的肝硬化合并急性消化道出血低风险患者

2025-11-220
OAAI
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021

可归因于代谢风险的原发性肝癌的全球,区域和国家负担: 对1990-2021全球疾病负担研究的分析

2025-10-017
PRE
Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018–2024)

墨西哥肝硬化患者中肝细胞癌的流行病学和病因学趋势:一项多中心回顾性研究(2018–2024)

2025-09-250
OAAI
The Mechanisms behind Thrombocytopenia in Patients with Portal Hypertension and Chronic Liver Disease

门静脉高压和慢性肝病患者的血小板减少症发生机制

2025-09-010
OA
Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification Implications

MASLD与代谢综合征之间的代谢差异:不同的临床表型及风险分层意义

2025-08-250
PRE
Non-invasive biomarkers for monitoring portal hypertension in metabolic dysfunction-associated steatotic liver disease (MASLD)

代谢功能障碍相关脂肪性肝病(MASLD)中用于监测门静脉高压的非侵入性生物标志物

2025-08-190
PRE
Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding

基于机器学习的CAGIB评分预测肝硬化患者急性消化道出血的院内死亡率

2025-07-310
OAAI
Changing Landscape of Liver Cirrhosis Etiologies

肝脏硬化病因学的变化趋势

2025-05-270
PRE
Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia

解析代谢相关脂肪性肝病(MAFLD)与肌少症之间的代谢通路

2025-05-140
OA
MAFLD vs. MASLD: a year in review

MAFLD vs. MASLD:年度回顾

2025-04-160
PRE
Global Burden of Major Chronic Liver Diseases in 2021

全球主要慢性肝病负担2021年

2025-04-010
PRE
Factors Associated With Advanced Liver Fibrosis in a Population With Type 2 Diabetes: A Multicentric Study in Mexico City

与2型糖尿病人群晚期肝纤维化相关的因素:墨西哥城一项多中心研究

2025-02-011
OAAI
MetALD: The Outcome of Living Under the Shadow of Alcohol for 4 Decades

MetALD:在酒精阴影下生活40年的后果

2025-02-011
PRE